Pharmaceutical Biology

This Collection of Traditional Chinese Medicine (TCM) and Diabetes Mellitus aimed to publish significant research on TCM in diabetes mellitus characterized by scientific rigor and the potential to advance the field. With the improvement in people's living standards and changes in the environment, the morbidity of diabetes mellitus is gradually increasing. The clinical management of diabetes mellitus focuses mainly on glycemic control and treating diabetic complications. TCM is remarkably effective for glycemic control and diabetic complications in diabetic patients. Recent preclinical research has focused on unraveling the molecular mechanisms underlying the therapeutic effects of TCM in diabetes mellitus. Understanding the molecular mechanisms under TCM and their benefits in diabetes mellitus will be invaluable for applying TCM and compounds derived from TCM, which will develop novel and effective pharmacotherapies for treating diabetes mellitus and diabetic complications.

Topics that will be covered in this Article Collection include but are not limited to:

1. Fundamental Research

• • Discovery of new active substances of Traditional Chinese Medicine for the treatment of diabetes mellitus or diabetic complications
  • Structure-activity relationship and structural modification of monomer compositions of Traditional Chinese Medicine for the treatment of diabetes mellitus or diabetic complications
  • Antidiabetic Pharmacology, Toxicology, and Pharmacokinetics of Traditional Chinese Medicine
  • Research and development of new formulations of Traditional Chinese Medicine to prevent and treat diabetes mellitus or diabetic complications

2. Clinical Studies

• • Clinical observation on antidiabetic effects of Traditional Chinese Medicine
  • Study on the prevention and treatment of Traditional Chinese Medicine in diabetes mellitus or diabetic complications
  • The intervention of Traditional Chinese Medicine on adverse events of drug application in diabetic patients

Studies on complex herbal extracts must characterize their chemical composition (e.g., HPLC fingerprinting analysis or quantization of major compounds). We welcome the following types of articles: original papers, reviews, perspectives, notes, and short communications.

---

Dr. Shusen Sun was a research scientist at Pfizer before his pharmacy career. He is an Associate Editor for Pharmaceutical Biology. His current research focuses on the effectiveness and safe use of medicines, pharmacovigilance, pharmacoepidemiology, and pharmacoeconomics.

Dr. Xuansheng Ding is a Professor in the School of Basic Medicine and Clinical Pharmacy of China Pharmaceutical University. His current research focuses on rational drug use, clinical drug evaluation, and cardiovascular pharmacology (diabetic complications).

Instructions for AuthorsSubmit an Article